SCHEMBL26645578

SCHEMBL26645578

CC(C)(C)OC(=O)N1CCn2nc(-c3ccc(Cl)cc3)cc2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 6/20 0.50
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ STS P08842 2/20 0.45
▸ NR1H2 P55055 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ ESR2 Q92731 1/20 0.43
▸ CNR1 P21554 1/20 0.42
▸ CNR2 P34972 1/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ CYP3A5 P20815 2/20 0.42
▸ CACNB4 O00305 1/20 0.42
▸ CACNA1A O00555 1/20 0.42
▸ CACNA1G O43497 1/20 0.42
▸ CACNG3 O60359 1/20 0.42
▸ CACNA1F O60840 1/20 0.42
▸ CACNA1H O95180 1/20 0.42
▸ CACNB3 P54284 1/20 0.42
▸ CACNA2D1 P54289 1/20 0.42
▸ CACNG7 P62955 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30623013 0.94 GRM5 (0.45) GRM5MEN1KMT2ASTSNR1H2
SCHEMBL30622973 0.89 GRM5 (0.41) GRM5MEN1KMT2ASTSNR1H2
SCHEMBL16711314 0.89 GRM5 (0.50) GRM5NR1H2
SCHEMBL26645030 0.88 HTT (0.55) GRM5MEN1KMT2ASTSNR1H2
SCHEMBL26645489 0.87 MEN1 (0.44) GRM5MEN1KMT2ANR1H2POLB
SCHEMBL26645099 0.87 GRM5 (0.48) GRM5STSNR1H2
SCHEMBL26645758 0.86 GRM5 (0.43) GRM5MEN1KMT2ANR1H2POLB
SCHEMBL30622947 0.85 CFTR (0.44) GRM5MEN1KMT2ANR1H2CACNB4
SCHEMBL26645632 0.85 CFTR (0.44) GRM5MEN1KMT2ANR1H2CACNB4
SCHEMBL26645345 0.85 CYP3A4 (0.48) GRM5MEN1KMT2ASTSNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback